LifeArc (formerly MRC Technology) is a medical research charity with a 25-year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients.
LifeArc pioneers new ways to turn great science into greater patient impact. It brings together a network of partners to tackle specific diseases and directly funds academic and early stage research. So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antimicrobial resistance.
Find out more at Lifearc.org or Twitter @lifearc1.